🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/07/2017 | 72,79 | 73,84 | 72,69 | 72,86 | +0,04% | 1,58% | 274.594 |
| 17/07/2017 | 74,09 | 74,57 | 72,64 | 72,83 | -1,60% | 2,60% | 259.686 |
| 14/07/2017 | 74,42 | 75,03 | 73,94 | 74,02 | -0,49% | 1,47% | 229.389 |
| 13/07/2017 | 73,28 | 74,60 | 71,99 | 74,39 | +1,41% | 3,57% | 376.384 |
| 12/07/2017 | 73,73 | 73,76 | 72,51 | 73,35 | -0,17% | 1,69% | 247.343 |
| 11/07/2017 | 73,87 | 74,18 | 72,69 | 73,47 | -0,36% | 2,02% | 311.142 |
| 10/07/2017 | 74,80 | 75,43 | 73,62 | 73,74 | -1,34% | 2,42% | 226.664 |
| 07/07/2017 | 74,71 | 75,15 | 74,19 | 74,73 | +0,08% | 1,29% | 208.871 |
| 06/07/2017 | 75,53 | 75,53 | 73,69 | 74,67 | -1,55% | 2,44% | 298.479 |
| 05/07/2017 | 75,30 | 76,31 | 74,29 | 75,85 | +0,60% | 2,69% | 405.880 |
| 03/07/2017 | 76,02 | 76,33 | 74,77 | 75,40 | -0,44% | 2,05% | 124.072 |
| 30/06/2017 | 75,86 | 76,44 | 74,97 | 75,73 | -0,02% | 1,95% | 249.267 |
| 29/06/2017 | 75,73 | 75,88 | 74,47 | 75,75 | +0,04% | 1,85% | 279.403 |
| 28/06/2017 | 74,77 | 75,80 | 73,42 | 75,71 | +1,85% | 3,18% | 344.324 |
| 27/06/2017 | 76,25 | 76,53 | 74,22 | 74,34 | -2,58% | 3,03% | 398.987 |
| 26/06/2017 | 77,62 | 77,62 | 75,95 | 76,30 | -1,26% | 2,15% | 249.267 |
| 23/06/2017 | 76,63 | 77,31 | 75,96 | 77,27 | +0,60% | 1,76% | 711.732 |
| 22/06/2017 | 75,48 | 77,34 | 75,13 | 76,81 | +2,44% | 2,93% | 958.915 |
| 21/06/2017 | 72,48 | 75,38 | 72,20 | 74,98 | +3,88% | 4,39% | 1.015.501 |
| 20/06/2017 | 72,21 | 72,89 | 71,85 | 72,18 | -0,04% | 1,45% | 338.233 |
| 19/06/2017 | 72,11 | 72,66 | 71,61 | 72,21 | +0,76% | 1,46% | 395.941 |
| 16/06/2017 | 71,15 | 72,21 | 71,15 | 71,67 | +0,27% | 1,48% | 683.199 |
| 15/06/2017 | 71,81 | 71,88 | 70,82 | 71,48 | -0,96% | 1,48% | 197.971 |
| 14/06/2017 | 71,65 | 72,47 | 71,30 | 72,17 | +0,60% | 1,64% | 268.983 |
| 13/06/2017 | 71,98 | 72,16 | 70,99 | 71,74 | +0,21% | 1,62% | 228.107 |
| 12/06/2017 | 70,86 | 72,55 | 70,77 | 71,59 | +0,33% | 2,52% | 1.012.455 |
| 09/06/2017 | 71,36 | 72,21 | 70,43 | 71,35 | +0,25% | 2,50% | 468.076 |
| 08/06/2017 | 71,69 | 71,70 | 70,69 | 71,17 | -0,79% | 1,41% | 266.419 |
| 07/06/2017 | 70,07 | 71,74 | 69,78 | 71,74 | +2,56% | 2,80% | 360.034 |
| 06/06/2017 | 69,82 | 71,17 | 69,30 | 69,95 | +0,12% | 2,69% | 173.926 |